Financial News
Cyclerion Therapeutics Inc (NQ: CYCN )
2.930
+0.330
(+12.69%)
Streaming Delayed Price
Updated: 9:50 AM EDT, Aug 23, 2024
Add to My Watchlist
All News about Cyclerion Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5850.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
March 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/27/image47.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/06/aapharma_6.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/445ab2e5-e10a-4eb7-a71e-fc9eb54317bc/small/cyclerion-logo-blue-png.png)
![](https://ml.globenewswire.com/media/445ab2e5-e10a-4eb7-a71e-fc9eb54317bc/small/cyclerion-logo-blue-png.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/image-american_eagle_outfitters.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/image-dollar_tree_.png?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 22, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 22, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://ml.globenewswire.com/media/445ab2e5-e10a-4eb7-a71e-fc9eb54317bc/small/cyclerion-logo-blue-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/28/image-facebook.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/image10.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19341.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/24/image39.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18886.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18782.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/07/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/06/image45.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18584.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/07/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/06/25.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/06/image14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/06/image30.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/445ab2e5-e10a-4eb7-a71e-fc9eb54317bc/small/cyclerion-logo-blue-png.png)
Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
October 06, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16868.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16044.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.